Transdermal delivery of hormones
US6923983B2 · kind B2 · utility
120Cited by
14References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2003 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Jul 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of a hormone; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and at least one volatile liquid. The invention also provides a method for administering at least one systemic acting hormone to an animal which comprises applying an effective amount of the hormone in the form of the drug delivery system of the present invention
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.